Close

Goldman Sachs Starts UroGen Pharma (URGN) at Neutral

May 29, 2019 4:27 AM EDT Send to a Friend
Goldman Sachs analyst Paul Choi initiates coverage on UroGen Pharma ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login